OPKO HEALTH INC (OPK) Stock Analyst Ratings
NASDAQ:OPK - Nasdaq - US68375N1037 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to OPK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.07. This target is 210.8% above the current price.
OPK was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about OPK.
In the previous month the buy percentage consensus was at a similar level.
OPK was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-04-25 | JP Morgan | Initiate | Neutral |
| 2025-04-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-17 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-07-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-29 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-15 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-05 | Piper Sandler | Maintains | Overweight |
| 2022-05-10 | Piper Sandler | Maintains | Overweight |